65,437 trials
Dermatosis Papulosa Nigra
Primary: Physician's DPN Lesions Assessment — -0.75; -1.38; -0.92 score on a scale (PLA)
Metastatic Beast Cancer
Primary: Progression-free Survival (PFS) Rate at 3 Months — 50.1 percent of participants
Metastatic Brain Cancer
Primary: Rate of Deterioration in Neurocognitive Functioning (NF) at Month 12 — 2.8 percentage of participants
Congenital Heart Block · Neonatal Lupus · Autoantibody-Associated Heart Block
Primary: Recurrence of Advanced Heart Block — 5 Participants
Anger Problems
Primary: Least Squares Mean Anger Expression Index Score on the State Trait Anger Inventory 2 (STAXI-2) Using a Repeated Measures ANCOVA Adjusted for Baseline and Time Effects…
Defect of Articular Cartilage
Primary: MRI Repair Tissue Comparison — 10; 2; 3; 4 Participants — p=0.61
Staph Aureus Colonization · Staph Aureus Infection
Primary: Number of Neonatal Infections With a S. Aureus Strain That is Concordant to Parental S. Aureus Strain — 13; 29 neonatal S. aureus infections
Chronic Pain · Back Pain
Primary: Percentage of Subjects With 50% or Greater Reduction in Overall Pain From Baseline — 31 Participants
Sleep Apnea
Primary: Number of Patients With Response to Stimulation (Diaphragmatic Movement Achieved) — 15 Participants
Androgenetic Alopecia
Primary: Change in Hair Diameter — 57.42; 51.58; 60.92; 51.17 micrometer
Pain · Postoperative Depression
Primary: Change in Pain Scores — 1.45; 1 score on a scale
Eosinophilic Esophagitis (EoE)
Primary: Number of Participants With Histologic Response at the Final Treatment Period Evaluation (Week 16) — 1; 113; 104; 100 Participants — p=<0.001
Carcinoma, Midline
Primary: Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)-Part 1 QD — 3; 4; 1; 3 Participants
Type 1 Diabetes
Primary: Change in Score of Pediatric Quality of Life Inventory 3.2 Diabetes Module (Peds QL 3.2) From Baseline to 3 Months — 6.4; -3.8 score on a scale
Dementia Alzheimers
Primary: Caregiver Burden